Luminary Therapeutics, Inc.
PrivateLast Round
Grant
Mar 11, 2025
Total Funding Raised
$59.53M
Company Overview
Luminary Therapeutics, Inc. is a clinical-stage biotechnology company developing allogeneic cell therapies using its proprietary gamma delta platform to target solid tumors and autoimmune disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B2C
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Luminary Therapeutics, Inc. Comparables
Compare Luminary Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iCell Gene Therapeutics | 82% | |
| Elpis Biopharmaceuticals | 81% | |
| AvenCell | 80% | |
Luminary Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 11, 2025 | ||||
| Grant | Jan 27, 2025 | ||||
| Grant | Oct 29, 2024 | ||||
| VC Round | Dec 21, 2022 | ||||
| Series A | Oct 14, 2022 | ||||
SAFE | Oct 14, 2021 |
Luminary Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| ARPA-H | Grant |
| Gopher Angels | Angel, Seed |
| Lunch Pail Ventures | Angel |
| NuFund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 29, 2024
$300K raised from Bio-Techne Corporation, ScaleReady, and Wilson Wolf.
Luminary Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Luminary Therapeutics, Inc.'s valuation, stock price, and market status.